Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1957 Aug 10;2(5040):343–345.

Tolbutamide in Diabetes

PMCID: PMC1962017  PMID: 13446477

Full text

PDF
343

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANDER A., CREUTZFELDT W., DORFMULLER T., EHRHART H., MARX R., MASKE H., MEIER W., MOHNIKE G., PFEIFFER E. F., SCHLAGINTWEIT S. Uber die orale Behandlung des Diabetes mellitus mit N-[4-Methylbenzolsulfonyl]-N'-butyl-harnstoff (D 860); klinische und experimentelle Untersuchungen. Dtsch Med Wochenschr. 1956 May 25;81(21):823–contd. doi: 10.1055/s-0028-1115797. [DOI] [PubMed] [Google Scholar]
  2. BEASER S. B. The use of orinase in diabetes. Metabolism. 1956 Nov;5(6 Pt 2):933–939. [PubMed] [Google Scholar]
  3. BERSON S. A., YALOW R. S. Some remarks on the mechanism of action of the sulfonylureas. Diabetes. 1957 May-Jun;6(3):274-7; discussion, 277-9. doi: 10.2337/diab.6.3.274. [DOI] [PubMed] [Google Scholar]
  4. COLWELL A. R., Sr, COLWELL A. R., Jr, COLWELL J. A. Intrapancreatic perfusion of the antidiabetic sulfonylureas. Metabolism. 1956 Nov;5(6 Pt 2):749–756. [PubMed] [Google Scholar]
  5. CONN J. W., FAJANS S. S., HENNES A. R., WAJCHENBERG B. L. Comparative effects of insulin and orinase on blood levels of pyruvate and alpha-ketoglutarate in normal subjects. Metabolism. 1957 Jan;6(1):63–69. [PubMed] [Google Scholar]
  6. DOLGER H. Clinical experience with orinase. Metabolism. 1956 Nov;5(6 Pt 2):947–952. [PubMed] [Google Scholar]
  7. KIRTLEY W. R. Occurrence of sensitivity and side reactions following carbutamide. Diabetes. 1957 Jan-Feb;6(1):72-3; discussion, 85-90. doi: 10.2337/diab.6.1.72. [DOI] [PubMed] [Google Scholar]
  8. SCHAMBYE P. On the action of BZ-55 and D-860 in pancreatectomized dogs. Diabetes. 1957 Mar-Apr;6(2):146–150. doi: 10.2337/diab.6.2.146. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES